Advertisement

Lung Cancer Screening in High-Risk Patients with Low-Dose Helical CT

  • Despina I. Savvidou
Chapter

Abstract

Most patients with NSCLC are diagnosed at a late stage because of lack of symptoms in early-stage disease, resulting in a very low 5-year survival. More than 50% of patients are diagnosed with metastatic disease [1, 2].

References

  1. 1.
    Swensen Stephen J, James R et al (2009) Lung cancer screening with CT: Mayo clinic experience 1. Radiology.  https://doi.org/10.1148/radiol.2263020036 CrossRefGoogle Scholar
  2. 2.
    Reddy C, Chilla D, Boltax J et al (2011) Lung cancer screening: a review of available data and current guidelines. Hosp Pract 39(4):107–112CrossRefGoogle Scholar
  3. 3.
    The National Lung Screening Trial Research Team (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409CrossRefGoogle Scholar
  4. 4.
    Kramer BS, Berg CD, Aberle DR (2011) Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST). J Med Screen 18(3):109–111CrossRefGoogle Scholar
  5. 5.
    Arjun N, Hansell David M (2011) European and North American lung cancer screening experience and implications for pulmonary nodule management. Eur Radiol 21:2445–2454CrossRefGoogle Scholar
  6. 6.
    Bach P, Mirkin Joshua N et al (2012) Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 307(22):2418–2429CrossRefGoogle Scholar
  7. 7.
    MacMahon H, Austin John HM, Gamsu G et al (2005) Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner society. Radiology 237:395–400CrossRefGoogle Scholar
  8. 8.
    Jacobson FL, Austin JH, Field JK et al (2012) Development of the American association for thoracic surgery guidelines for low-dose computed tomography scans to screen for lung cancer in north America: recommendations of the American association for thoracic surgery task force for lung cancer screening and surveillance. J Thorac Cardiovasc Surg 144(1):25–32CrossRefGoogle Scholar
  9. 9.
    Richard W, Elizabeth F, Ermilo B et al (2013) American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 63:106–117CrossRefGoogle Scholar
  10. 10.
    Virginia M (2014) Screening for lung cancer: U.S Preventive Services Task Force Recommendation Statement. Ann Intern Med 160:330–338Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Despina I. Savvidou
    • 1
  1. 1.CT and MRI DepartmentBiomedicineAthensGreece

Personalised recommendations